Related references
Note: Only part of the references are listed.Impact of Inoculum Size and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus (hVISA) on Vancomycin Activity and Emergence of VISA in an In Vitro Pharmacodynamic Model
Warren E. Rose et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Evaluation of the Etest GRD for the detection of Staphylococcus aureus with reduced susceptibility to glycopeptides
Steven N. Leonard et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Vancomycin Heteroresistance and Methicillin-Resistant Staphylococcus aureus
Stan Deresinski
JOURNAL OF INFECTIOUS DISEASES (2009)
Clinical Features of Heteroresistant Vancomycin-Intermediate Staphylococcus aureus Bacteremia versus Those of Methicillin-Resistant S. aureus Bacteremia
Yasmin Maor et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Evaluation of a new etest vancomycin-teicoplanin strip for detection of glycopeptide-intermediate Staphylococcus aureus (GISA), in particular, heterogeneous GISA
Anne Yusof et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Characterization of vancomycin-heteroresistant Staphylococcus aureus from the metropolitan area of Detroit, Michigan, over a 22-year period (1986 to 2007)
Michael J. Rybak et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Prevalence and charactenistics of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia in a tertiary care center
Yasmin Maor et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
A multicenter study evaluating the current strategies for isolating Staphylococcus aureus strains with reduced susceptibility to glycopeptides
Mandy Wootton et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
Bactericidal agents in the treatment of MRSA infections - the potential role of daptomycin
G. L. French
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Daptomycin bactericidal activity and correlation between disk and broth microdilution method results in testing of Staphylococcus aureus strains with decreased susceptibility to vancomycin
Helio S. Sader et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Oxazolidinone susceptibility patterns in 2004:: report from the Zyvox® Annual Appraisal of Potency and Spectrum (ZAAPS) Program assessing isolates from 16 nations
RN Jones et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Activity of glycopeptides against Staphylococcus aureus infection in a rabbit endocarditis model:: MICs do not predict in vivo efficacy
N Asseray et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of gram-positive bacterial infections
GA Pankey et al.
CLINICAL INFECTIOUS DISEASES (2004)
Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model
KL LaPlante et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Staphylococcus aureus with heterogeneous resistance to vancomycin:: Epidemiology, clinical significance, and critical assessment of diagnostic methods
C Liu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Vancomycin treatment failure associated with heterogeneous vancomycin-intermediate Staphylococcus aureus in a patient with endocarditis and in the rabbit model of endocarditis
MR Moore et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides
TR Walsh et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2001)
Share Paper
